Table 1. Detection of EHV-5 in blood obtained on day 0 before infection and on sampling days 4 to 49 after infection.
Day PI | C110y | C2a 16y | E1* 19y | E220y | E317y | E4** 17y | E526y | E616y |
---|---|---|---|---|---|---|---|---|
0 | − | VC | V§ | V | − | − | − | − |
4 | − | VC | ND | − | − | B | − | − |
7 | − | VC | ND | − | − | − | − | − |
11 | − | VC | ND | V | − | − | − | − |
14 | − | VC | ND | − | − | − | − | − |
21 | ND | VC | ND | − | − | − | V | − |
28 | ND | VC | ND | − | B, VC | − | − | − |
35 | ND | VC | ND | − | − | − | − | − |
42 | ND | VC | ND | V | − | − | − | − |
49 | ND | VC | ND | − | − | − | − | − |
a Horse C2 was naturally infected with an EHV-5 that was designated as VC. This horse was in contact with other horses in the study before separate housing was initiated.
* Horses E1, E2, and E3 were experimentally infected with an EHV-5 designated as A
** Horses E4, E5, and E6 were experimentally infected with an EHV-5 designated as B -; negative; ND: not done; V: several genetically identifiable EHV-5 were detected in blood from the horses, those viruses are collectively designated as V. The age of all horses in years (y) is denoted in subscript.